Smith, L. M., Mahoney, D. W., Bamlet, W. R., Yu, F., Liu, S., Goggins, M. G., Darabi, S., Majumder, S., Wang, Q.-L., Coté, G. A., Demeure, M. J., Zhang, Z., Srivastava, S., Chawla, A., Izmirlian, G., Olson, J. E., Wolpin, B. M., Genkinger, J. M., Zaret, K. S., … Oberg, A. L. (2024). Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies. Pancreatology, 24(8), 1265–1279. https://doi.org/10.1016/j.pan.2024.10.012

Baraban, E. G., Gru, A., Guo, R., Elias, R., Pallavajjala, A., Dudley, J. C., & Gross, J. M. (2024). Neurofibroma-like Desmoplastic Melanoma. American Journal of Surgical Pathology. https://doi.org/10.1097/pas.0000000000002327

Faiena, I., Adhikary, S., Schweitzer, C., Astrow, S. H., Grogan, T., Funt, S. A., Bot, A., Dorff, T., Rosenberg, J. E., Elashoff, D. A., Pantuck, A. J., & Drakaki, A. (2024). Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non–Small-Cell Lung Carcinoma and Urothelial Carcinomas. Journal of Immunotherapy. https://doi.org/10.1097/cji.0000000000000538

Zhang, C., Zhao, N., Khan, R., Hung, M., Zhang, C., Wang, S., Wang, T. J. C., & Lin, C. (2024). The prognostic significance of androgen receptor expression in gliomas. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-72284-4

Manukyan, I., Hsiao, S. J., Fazlollahi, L., Remotti, H., & Mansukhani, M. M. (2024). Molecular and morphologic characterization of intraductal tubulopapillary neoplasms of pancreas with novel potentially targetable fusions. Human Pathology, 150, 36–41. https://doi.org/10.1016/j.humpath.2024.06.014

Furtado, L. V., Bifulco, C., Dolderer, D., Hsiao, S. J., Kipp, B. R., Lindeman, N. I., Ritterhouse, L. L., Temple-Smolkin, R. L., Zehir, A., & Nowak, J. A. (2024). Recommendations for Tumor Mutational Burden Assay Validation and Reporting. The Journal of Molecular Diagnostics, 26(8), 653–668. https://doi.org/10.1016/j.jmoldx.2024.05.002

Hua, X., Zhou, H., Wu, H.-C., Furnari, J., Kotidis, C. P., Rabadan, R., Genkinger, J. M., Bruce, J. N., Canoll, P., Santella, R. M., & Zhang, Z. (2024). Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50471-1

Cherng, H.-J. J., & Herrera, A. (2024). Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside? Current Treatment Options in Oncology, 25(5), 659–678. https://doi.org/10.1007/s11864-024-01201-8

Garlin-Politis, M., Upadhyay Baskota, S., Picon, S., Collins, N., Virk, R. K., Cimic, A., Yousefi, E., & Gonzalez, A. (2024). CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation. Journal of the American Society of Cytopathology, 13(3), 213–218. https://doi.org/10.1016/j.jasc.2024.02.002

Smithgall, M. C., Remotti, H., Hsiao, S. J., Mansukhani, M., Liu-Jarin, X., & Fernandes, H. (2022). Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing. Human Pathology, 119, 41–50. https://doi.org/10.1016/j.humpath.2021.10.004

Zhang, X., Wolff, M. S., Shen, J., Parada, H., Santella, R. M., Neugut, A. I., Chen, J., & Teitelbaum, S. L. (2022). Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project. Cancer Epidemiology, Biomarkers & Prevention, 31(1), 117–123. https://doi.org/10.1158/1055-9965.epi-21-0830

Yan, H., Yu, C.-C., Fine, S. A., Youssof, A. L., Yang, Y.-R., Yan, J., Karg, D. C., Cheung, E. C., Friedman, R. A., Ying, H., Chen, E. I., Luo, J., Miao, Y., Qiu, W., & Su, G. H. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene, 40(50), 6759–6771. https://doi.org/10.1038/s41388-021-02040-9

Ayton, S. G., Pavlicova, M., Robles-Espinoza, C. D., Tamez Peña, J. G., & Treviño, V. (2022). Multiomics subtyping for clinically prognostic cancer subtypes and personalized therapy: A systematic review and meta-analysis. Genetics in Medicine, 24(1), 15–25. https://doi.org/10.1016/j.gim.2021.09.006

Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D’Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., Sharp, A., Sheehan, B., Christova, R., Seed, G., Figueiredo, I., Lambros, M., Dolling, D., Rekowski, J., Alajati, A., … de Bono, J. (2021). HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer Research, 81(24), 6207–6218. https://doi.org/10.1158/0008-5472.can-21-3360

Farré, P. L., Duca, R. B., Massillo, C., Dalton, G. N., Graña, K. D., Gardner, K., Lacunza, E., & De Siervi, A. (2021). MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis. International Journal of Molecular Sciences, 22(20), 11135. https://doi.org/10.3390/ijms222011135

Park, S., Rong, L., Owczarek, T. B., Bernardo, M. D., Shoulson, R. L., Chua, C.-W., Kim, J. Y., Lankarani, A., Chakrapani, P., Syed, T., McKiernan, J. M., Solit, D. B., Shen, M. M., Al-Ahmadie, H. A., & Abate-Shen, C. (2021). Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression. Cancer Research, 81(20), 5161–5175. https://doi.org/10.1158/0008-5472.can-21-1254

Rivas, M. A., Durmaz, C., Kloetgen, A., Chin, C. R., Chen, Z., Bhinder, B., Koren, A., Viny, A. D., Scharer, C. D., Boss, J. M., Elemento, O., Mason, C. E., & Melnick, A. M. (2021). Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.688493